Cellromax Science Co., Ltd. (KOSDAQ:471820)
South Korea · Delayed Price · Currency is KRW 5,020.00
+165.00 (3.40%)
At close: May 14, 2026
Cellromax Science Market Cap
Cellromax Science has a market cap or net worth of 55.42 billion as of May 15, 2026. Its market cap has decreased by -10.70% in one year.
Market Cap
55.42B
Enterprise Value
48.20B
Revenue
22.18B
Ranking
n/a
PE Ratio
19.23
Stock Price
5,020.00
Market Cap Chart
Since December 13, 2024, Cellromax Science's market cap has decreased from 92.69B to 55.42B, a decrease of -40.20%. That is a compound annual growth rate of -30.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 53.88B | -26.77% |
| Dec 30, 2025 | 73.57B | 28.56% |
| Dec 30, 2024 | 57.23B | -38.25% |
| Dec 13, 2024 | 92.69B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GITSN | 71.27B |
| ERCOHS Agricultural Corporation Co.,Ltd | 70.84B |
| Laseroptek | 68.58B |
| ALT Co., Ltd. | 56.90B |
| Bowon Chemical | 56.39B |
| NH Special Purpose Acquisition 29 Company | 54.96B |
| JNB Co., Ltd. | 52.89B |
| Korea No.14 Special Purpose Acquisition | 51.35B |